163 related articles for article (PubMed ID: 31744508)
21. Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.
Zaborsky N; Gassner FJ; Höpner JP; Schubert M; Hebenstreit D; Stark R; Asslaber D; Steiner M; Geisberger R; Greil R; Egle A
Leukemia; 2019 Apr; 33(4):957-968. PubMed ID: 30262843
[TBL] [Abstract][Full Text] [Related]
22. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.
Geisler CH; Philip P; Christensen BE; Hou-Jensen K; Pedersen NT; Jensen OM; Thorling K; Andersen E; Birgens HS; Drivsholm A; Ellegaard J; Larsen JK; Plesner T; Brown P; Andersen PK; Hansen MM
Leuk Res; 1997; 21(11-12):1011-23. PubMed ID: 9444933
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients.
Öztürk S; Paul Y; Afzal S; Gil-Farina I; Jauch A; Bruch PM; Kalter V; Hanna B; Arseni L; Roessner PM; Schmidt M; Stilgenbauer S; Dietrich S; Lichter P; Zapatka M; Seiffert M
Leukemia; 2022 Feb; 36(2):464-475. PubMed ID: 34417556
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse.
Braggio E; Kay NE; VanWier S; Tschumper RC; Smoley S; Eckel-Passow JE; Sassoon T; Barrett M; Van Dyke DL; Byrd JC; Jelinek DF; Shanafelt TD; Fonseca R
Leukemia; 2012 Jul; 26(7):1698-701. PubMed ID: 22261920
[No Abstract] [Full Text] [Related]
25. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
26. Descriptive analysis of genetic aberrations and cell of origin in Richter transformation.
Chitalia A; Swoboda DM; McCutcheon JN; Ozdemirli M; Khan N; Cheson BD
Leuk Lymphoma; 2019 Apr; 60(4):971-979. PubMed ID: 30632835
[TBL] [Abstract][Full Text] [Related]
27. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia.
Wang J; Khiabanian H; Rossi D; Fabbri G; Gattei V; Forconi F; Laurenti L; Marasca R; Del Poeta G; Foà R; Pasqualucci L; Gaidano G; Rabadan R
Elife; 2014 Dec; 3():. PubMed ID: 25496728
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.
Shanafelt TD; Witzig TE; Fink SR; Jenkins RB; Paternoster SF; Smoley SA; Stockero KJ; Nast DM; Flynn HC; Tschumper RC; Geyer S; Zent CS; Call TG; Jelinek DF; Kay NE; Dewald GW
J Clin Oncol; 2006 Oct; 24(28):4634-41. PubMed ID: 17008705
[TBL] [Abstract][Full Text] [Related]
29. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
Nadeu F; Clot G; Delgado J; Martín-García D; Baumann T; Salaverria I; Beà S; Pinyol M; Jares P; Navarro A; Suárez-Cisneros H; Aymerich M; Rozman M; Villamor N; Colomer D; González M; Alcoceba M; Terol MJ; Navarro B; Colado E; Payer ÁR; Puente XS; López-Otín C; López-Guillermo A; Enjuanes A; Campo E
Leukemia; 2018 Mar; 32(3):645-653. PubMed ID: 28924241
[TBL] [Abstract][Full Text] [Related]
30. Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome.
Steinbrecher D; Jebaraj BMC; Schneider C; Edelmann J; Cymbalista F; Leblond V; Delmer A; Ibach S; Tausch E; Scheffold A; Bloehdorn J; Hallek M; Dreger P; Döhner H; Stilgenbauer S
Leuk Lymphoma; 2018 Jul; 59(7):1614-1623. PubMed ID: 29063805
[TBL] [Abstract][Full Text] [Related]
31. Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.
Wawrzyniak E; Kotkowska A; Blonski JZ; Siemieniuk-Rys M; Ziolkowska E; Giannopoulos K; Robak T; Korycka-Wolowiec A
Eur J Haematol; 2014 Feb; 92(2):91-101. PubMed ID: 24138550
[TBL] [Abstract][Full Text] [Related]
32. The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.
Stankovic T; Skowronska A
Leuk Lymphoma; 2014 Jun; 55(6):1227-39. PubMed ID: 23906020
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.
Mátrai Z; Andrikovics H; Szilvási A; Bors A; Kozma A; Ádám E; Halm G; Karászi É; Tordai A; Masszi T
Pathol Oncol Res; 2017 Jan; 23(1):165-171. PubMed ID: 27757836
[TBL] [Abstract][Full Text] [Related]
34. Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.
Zapatka M; Tausch E; Öztürk S; Yosifov DY; Seiffert M; Zenz T; Schneider C; Blöhdorn J; Döhner H; Mertens D; Lichter P; Stilgenbauer S
Haematologica; 2022 Mar; 107(3):604-614. PubMed ID: 33691380
[TBL] [Abstract][Full Text] [Related]
35. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.
Koski T; Karhu R; Visakorpi T; Vilpo L; Knuutila S; Vilpo J
Eur J Haematol; 2000 Jul; 65(1):32-9. PubMed ID: 10914937
[TBL] [Abstract][Full Text] [Related]
36. Elevated
Bravo-Navas S; Yáñez L; Romón Í; Pipaón C
FASEB J; 2019 Sep; 33(9):10477-10489. PubMed ID: 31251079
[TBL] [Abstract][Full Text] [Related]
37. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
38. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
[TBL] [Abstract][Full Text] [Related]
39. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
Smith EN; Ghia EM; DeBoever CM; Rassenti LZ; Jepsen K; Yoon KA; Matsui H; Rozenzhak S; Alakus H; Shepard PJ; Dai Y; Khosroheidari M; Bina M; Gunderson KL; Messer K; Muthuswamy L; Hudson TJ; Harismendy O; Barrett CL; Jamieson CH; Carson DA; Kipps TJ; Frazer KA
Blood Cancer J; 2015 Apr; 5(4):e303. PubMed ID: 25860294
[TBL] [Abstract][Full Text] [Related]
40. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
